Anaptysbio, inc (ANAB)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss) Attributable to Parent

-8,262

-20,263

-31,033

-23,962

-22,078

-16,994

-15,958

-13,618

-15,086

-6,861

-9,090

-2,684

-11,435

-4,578

-1,115

2,322

-888

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

140

140

135

124

115

106

91

64

54

47

46

51

39

58

58

60

57

Stock-based compensation

2,975

2,757

3,144

3,643

2,867

2,621

2,532

2,548

2,260

1,132

942

1,438

866

288

255

295

322

Fair Value Adjustment of Warrants

-

-

-

-

-

-

-

-

-

0

0

0

1,366

1,091

47

-3

-379

Accretion/amortization of investments, net

8

184

523

898

1,028

678

300

172

83

-

-

-

-

-

-

-

-

(Income) loss from investments

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Non-cash interest expense

0

-173

-171

-168

-164

-165

-164

-161

-156

-159

-157

-153

-150

-25

-30

-28

-22

Income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-139

Changes in operating assets and liabilities:
Receivable from collaborative partners

5,000

0

-5,000

5,000

0

-

-

-

-

0

0

0

-1,225

365

-120

-211

-35

Australian tax incentive receivable

-

-

-

-

-

1

21

-1,458

9

115

-4,151

672

847

825

695

2,598

0

Prepaid expenses and other assets

-233

-253

-490

-2,650

1,215

3,785

217

1,574

-388

304

-909

2,347

143

568

139

56

316

Accounts payable and other liabilities

-5,190

1,319

520

7,584

5,076

1,137

3,849

2,255

-158

1,137

-1,019

1,418

682

832

-280

1,792

-1,093

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,529

-1,354

-382

323

Net cash used in operating activities

-15,112

-15,805

-22,096

-15,517

-16,099

-12,290

-14,860

-8,878

-12,478

-4,810

-3,888

-2,643

-8,097

-5,570

-3,073

1,669

-2,056

CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of investments

74,013

76,766

42,736

52,550

79,763

223,542

33,584

58,208

32,203

180,204

21,348

62,353

27,000

0

0

0

0

Sales and maturities of investments

84,851

80,905

102,879

110,667

89,600

57,598

58,520

55,450

34,581

27,271

20,866

0

0

-

-

-

-

Purchases of property and equipment

87

104

280

241

180

206

321

304

232

124

13

68

85

1

0

14

35

Net cash provided by investing activities

10,751

4,035

59,863

57,876

9,657

-166,150

24,615

-3,062

2,146

-153,057

-495

-62,421

-27,085

-1

0

-14

-35

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Issuance of Common Stock

-

-

-

-

-

-

-

-

-

212,324

0

0

80,213

0

0

0

0

Proceeds from issuance of common stock, upon the exercise of stock options

36

1,757

454

215

574

731

669

1,397

72

165

311

148

355

15

7

0

9

Proceeds from issuance of common stock, upon the exercise of warrants

-

-

-

-

-

0

0

1

75

0

1

0

535

0

0

0

0

Payments on notes payable

1,375

1,875

1,875

1,875

1,875

1,875

1,875

1,875

1,250

0

0

0

0

-

-

-

-

Payments for repurchase of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1

Payments for offering costs, net

-

-

-

-

-

-

-

0

280

-

-

1,086

399

91

386

387

283

Net cash used in financing activities

-1,339

-111

-1,421

-1,660

-1,301

-1,372

226,596

-477

-1,383

212,387

300

-938

80,704

9,669

-379

-387

-275

Net decrease in cash, cash equivalents, and restricted cash

-5,700

-11,881

36,346

40,699

-7,743

-179,812

236,351

-12,417

-11,715

54,520

-4,083

-66,002

45,522

4,098

-3,452

1,268

-2,366

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid

4

40

83

129

172

208

250

288

297

327

293

191

278

93

87

87

87

Non-cash investing and financing activities:
Amounts accrued for property and equipment

86

-41

68

-219

233

-1

-34

187

7

179

3

-43

52

104

0

-7

7

Amounts accrued for offering costs

-

-

-

-

-

-

-

-

-

-

-

-

1,290

350

-251

490

260

Reclassification of warrants to equity

-

-

-

-

-

-

-

-

-

0

0

0

4,607

0

0

0

0